Under typical market conditions, this fund aims to allocate a substantial portion—at least 80%—of its net assets (along with any borrowed capital for investment) to holdings directly or indirectly associated with Eli Lilly and Company (LLY). This includes the company's stock, other instruments designed to track LLY's performance, or income-producing assets connected to LLY. The main strategy for gaining exposure to LLY's performance involves utilizing options contracts on LLY shares, encompassing both standard exchange-traded options and specialized Flexible Exchange® Options (FLEX Options).